hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 5.00
-0.20 (-3.85%)
At close: Dec 5, 2025
hVIVO Market Cap
hVIVO has a market cap or net worth of 34.02 million as of December 5, 2025. Its market cap has decreased by -75.00% in one year.
Market Cap
34.02M
Enterprise Value
25.43M
Revenue
54.47M
Ranking
n/a
PE Ratio
6.50
Stock Price
5.00
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 34.02M, an increase of 97.35%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.02M | -75.61% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | 172.36M | 1,388.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |